末梢神経損傷の市場規模、シェア、成長分析：損傷タイプ別、製品別、治療別、手術別、用途別、地域別 - 産業予測、2024-2031年

末梢神経損傷の市場規模は2022年に14億3,000万米ドルと評価され、予測期間（2024-2031年）のCAGRは7.65%で、2023年の15億4,000万米ドルから2031年には27億8,000万米ドルに成長する見通しです。

近年、外傷関連事故の増加、神経修復技術の進歩、高齢化などの要因によって、末梢神経損傷市場は著しい進歩を遂げています。手術方法や生体材料の改良が患者の予後を著しく向上させ、市場の拡大を促しています。神経刺激療法や神経調節療法も治療の選択肢を多様化しています。学界、医療企業、研究機関の連携が革新的な治療開発に拍車をかけています。とはいえ、高額な治療費や限られた償還額といった課題は依然として残っています。市場関係者は、効果的なソリューションへの需要が高まる中、こうしたハードルを乗り越えなければならず、この分野をヘルスケアにおけるダイナミックなものにしています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 技術分析
• バリューチェーン分析
• 価格分析
• スタートアップ分析
• 規制情勢
• 特許分析
• パイプライン分析
• 重要成功要因
• 市場の魅力指数
• 競合の程度
• 主な投資機会
• エコシステムマッピング

末梢神経損傷市場：損傷タイプ別

• 市場概要
• 外傷
• 圧迫損傷
• 外科的損傷

末梢神経損傷市場：製品別

• 市場概要
• 神経導管
• 神経保護具
• 神経コネクター
• 神経ラップ

末梢神経損傷市場：治療別

• 市場概要
• 外科的介入
• 理学療法
• 薬物療法

末梢神経損傷市場：手術別

• 市場概要
• 直接神経修復
• 神経移植
• 幹細胞療法

末梢神経損傷市場：用途別

• 市場概要
• 下肢
• 上肢

末梢神経損傷市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Medtronic plc（Ireland）
• Boston Scientific Corporation（United States）
• Abbott Laboratories（United States）
• Stryker Corporation（United States）
• Baxter International Inc.（United States）
• Integra LifeSciences Holdings Corporation（United States）
• Axogen Corporation（United States）
• NeuroPace, Inc.（United States）
• Nuvectra Corporation（United States）
• OrthoPediatrics Corp.（United States）
• Polyganics BV（Netherlands）
• Zimmer Biomet Holdings, Inc.（United States）
• Smith & Nephew plc（United Kingdom）
• NeuroMetrix, Inc.（United States）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Natus Medical Incorporated（United States）
• LivaNova plc（United Kingdom）
• AxoGen Corporation（United States）
• Bioventus LLC（United States）

Peripheral Nerve Injuries Market size was valued at USD 1.43 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 2.78 billion by 2031, at a CAGR of 7.65% during the forecast period (2024-2031).

Recent years have witnessed significant advancements in the peripheral nerve injuries market, fueled by factors such as rising trauma-related incidents, advancements in nerve repair technologies, and an aging population. Improvements in surgical methods and biomaterials have notably enhanced patient outcomes, stimulating market expansion. Neurostimulation and neuromodulation therapies have also diversified treatment options. Collaborations among academia, medical firms, and research entities have spurred innovative therapy development. Nevertheless, challenges like high treatment costs and limited reimbursements persist. Market stakeholders must navigate these hurdles amidst growing demand for effective solutions, making this sector dynamic within healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Nerve Injuries Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Nerve Injuries Market Segmental Analysis

The peripheral nerve injuries market can be segmented based on injury type, product, treatment, surgery, application, and region. Based on injury type, the market is segmented into traumatic injuries, compression injuries, and surgical injuries. Based on product, the market is segmented into nerve conduit, nerve protector, nerve connector, and nerve wraps. Based on treatment, the market is segmented into surgical interventions, physical therapy, and pharmaceutical interventions. Based on surgery, the market is segmented into direct nerve repair, nerve grafting, and stem cell therapy. Based on application, the market is segmented into lower extremities and upper extremities. Geographically, the market is divided into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Peripheral Nerve Injuries Market

Technological advancements, including the development of innovative wound care products and minimally invasive surgical techniques, significantly drive growth in the Peripheral Nerve Injuries Market. These innovations enhance the effectiveness and efficiency of burn treatments, resulting in improved patient outcomes and shorter recovery times.

Restraints in the Peripheral Nerve Injuries Market

The treatment expenses associated with peripheral nerve injuries, encompassing surgeries, rehabilitation, and ongoing care, can impose significant financial burdens. These high costs often restrict access to care for many patients and hinder market expansion. Furthermore, despite advancements in medical technology, treatment options for peripheral nerve injuries remain limited. Nerve regeneration is intricate, and achieving full recovery remains elusive, posing considerable challenges for both patients and healthcare providers alike.

Market Trends of the Peripheral Nerve Injuries Market

Technological advancements in nerve repair are a key trend in the peripheral nerve injuries market, marked by ongoing developments in nerve regeneration technologies. Researchers and medical device firms are innovating with nerve conduits, neurostimulation devices, and bioengineered materials to enhance treatment outcomes. These advancements aim to accelerate nerve regeneration, shorten recovery periods, and mitigate complications. Concurrently, there is an increasing incidence of peripheral nerve injuries, driven by factors like sports-related trauma, accidents, and an aging population, expanding the patient base in need of effective treatments. Additionally, personalized medicine is gaining traction, tailoring treatments based on injury type, severity, patient demographics, and health status, promising improved efficacy and minimized adverse effects.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Peripheral Nerve Injuries Market by Injury Type

• Market Overview
• Traumatic Injuries
• Compression Injuries
• Surgical Injuries

Peripheral Nerve Injuries Market by Product

• Market Overview
• Nerve Conduit
• Nerve Protector
• Nerve Connector
• Nerve Wraps

Peripheral Nerve Injuries Market by Treatment

• Market Overview
• Surgical Interventions
• Physical Therapy
• Pharmaceutical Interventions

Peripheral Nerve Injuries Market by Surgery

• Market Overview
• Direct Nerve Repair
• Nerve Grafting
• Stem Cell Therapy

Peripheral Nerve Injuries Market by Application

• Market Overview
• Lower Extremities
• Upper Extremities

Peripheral Nerve Injuries Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axogen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoPediatrics Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AxoGen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments